Gyorgy Baffy, MD, PhD

Adjunct Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Gyorgy Baffy is an Associate Professor of Medicine at Harvard Medical School, Adjunct Associate Professor of Medicine in Gastroenterology at Boston University, and Chief of Gastroenterology at the VA Boston Healthcare System. He is a graduate of the University Medical School of Debrecen in Hungary. In addition, he obtained his PhD from his studies on growth factor-mediated calcium signaling as an NIH Fogarty Fellow in the Department of Biochemistry and Biophysics at the University of Pennsylvania. He trained in gastroenterology at the University of Michigan and the Brigham and Women’s Hospital. His research interests focus on various aspects of nonalcoholic fatty liver disease such as outcomes prediction, biomarkers of lipotoxicity, metabolic reprogramming, cancer bioenergetics, and hepatocellular carcinoma. He has been involved in various clinical trials that pertain to colorectal cancer screening. He organized multiple workshops and symposia on his research topics at major US conferences. He published over 60 peer-reviewed papers and book chapters. He has participated in numerous scientific review panels and provides editorial work for several journals in gastroenterology and hepatology. In 2014, he received a Fulbright US Scholar award to teach for a semester about current issues of obesity and related disorders at the University of Debrecen. He is a Fellow of the American College of Physicians, American Gastroenterological Association, and the American Association for the Study of Liver Diseases. He is the recipient of the Madaus Prize from the Madaus Liver Foundation and the Hetényi Medal of the Hungarian Gastroenterological Association.

Publications

  • Published 6/1/2026

    Verma M, Navarro V, Kosinski A, Taddei T, Kalman R, Barritt Iv AS, Jakab S, Serper M, Orman E, Balakrishnan M, Rakoski M, Rockey D, Hunt K, Cabrera R, Aytaman A, John B, Baffy G, Nathan R, Tapper E, Roytman M, McGuire B, Hoppmann N, Woodrell C, Bakitas M, Yue Y, Reeve B, Lin L, Tantala R, Volk M. Palliative Care Intervention for Patients With End-Stage Liver Disease: A Cluster Randomized Clinical Trial. JAMA Intern Med. 2026 Jun 01; 186(6):677-686. PMID: 41973444.

    Read at: PubMed

  • Published 4/24/2026

    Bromfield B, Chimene-Weiss J, Gheewalla G, Feldman T, Mitten EK, Portincasa P, Baffy G. Prediction of trajectories and outcomes in early-stage metabolic dysfunction-associated steatotic liver disease: a narrative review. EClinicalMedicine. 2026 May; 95:103921. PMID: 42065100.

    Read at: PubMed

  • Published 8/28/2025

    Mahdi L, Graziani A, Baffy G, Mitten EK, Portincasa P, Khalil M. Unlocking Polyphenol Efficacy: The Role of Gut Microbiota in Modulating Bioavailability and Health Effects. Nutrients. 2025 Aug 28; 17(17). PMID: 40944183.

    Read at: PubMed

  • Published 8/28/2025

    Portincasa P, Luglio CV, Sozzi S, Conforti C, Bitonto G, Papavero M, Baffy G, Di Ciaula A. Opioid-induced constipation in internal medicine: recognition and management pathways. Intern Emerg Med. 2025 Sep; 20(6):1695-1704. PMID: 40877716.

    Read at: PubMed

  • Published 5/23/2025

    Baffy G, Mitten EK, Portincasa P. Is MetALD an all-inclusive term for liver disease caused by alcohol and metabolic dysfunction? J Hepatol. 2025 Sep; 83(3):e166-e168. PMID: 40414508.

    Read at: PubMed

View All 89 Publications:   View Full Profile in BUMC

Websites

Education

  • University of Debrecen, MD
  • Hungarian Academy of Sciences, PhD

View all profiles